• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多功能基因载体介导的肿瘤靶向基因组编辑调控细胞行为。

Tumor targeted genome editing mediated by a multi-functional gene vector for regulating cell behaviors.

机构信息

Key Laboratory of Biomedical Polymers of Ministry of Education, Department of Chemistry, Wuhan University, Wuhan 430072, People's Republic of China.

Key Laboratory of Biomedical Polymers of Ministry of Education, Department of Chemistry, Wuhan University, Wuhan 430072, People's Republic of China.

出版信息

J Control Release. 2018 Dec 10;291:90-98. doi: 10.1016/j.jconrel.2018.10.018. Epub 2018 Oct 16.

DOI:10.1016/j.jconrel.2018.10.018
PMID:30339905
Abstract

For effective regulation of cell behaviors and prevention of tumor development by genome editing, we constructed multi-functional self-assembled nanoparticles based on natural polymers to deliver CRISPR-Cas9 plasmid to tumorous cells. The CRISPR based gene editing plasmid to knockout CDK11 gene was complexed with protamine sulfate, and then the complex was decorated by a multi-functional outer layer composed of an endosomolytic peptide (KALA) and aptamer AS1411 incorporated carboxymethyl chitosan. The resultant multi-functional nanoparticles, which exhibit significantly enhanced delivery efficiency, can specifically deliver the plasmid into tumor cell nuclei owing to the favorable effects of KALA in cellular uptake and endosomal escape, together with the cancer cell and cell nucleus targeting capability of AS1411 ligands. The genome editing mediated by the nanoparticles leads to a dramatic decrease (>75%) in CDK11 expression, which results in further modulation of cancer cells with significant down-regulation of the proteins (MMP-9 and VEGF) involved in tumor development and metastasis as well as up-regulation of the tumor suppressor protein p53. More importantly, the detection of immune-related proteins after genome editing shows that the significantly enhanced Fas, CD80, MICA, MICB, and HLA-1 expression and decreased CD47 and MUC1 expression, indicating the genome editing is favorable for reversal of tumor-induced immunosuppression and prevention of tumor development.

摘要

为了通过基因组编辑有效地调节细胞行为和预防肿瘤的发展,我们构建了基于天然聚合物的多功能自组装纳米粒子,将 CRISPR-Cas9 质粒递送到肿瘤细胞中。基于 CRISPR 的基因编辑质粒用于敲除 CDK11 基因,与硫酸鱼精蛋白复合,然后由多功能外层修饰,该外层由内溶酶体肽(KALA)和结合羧甲基壳聚糖的适体 AS1411 组成。所得的多功能纳米粒子表现出显著增强的递送效率,由于 KALA 在细胞摄取和内涵体逃逸中的有利作用,以及 AS1411 配体对癌细胞和细胞核的靶向能力,能够将质粒特异性递送至肿瘤细胞核内。纳米粒子介导的基因组编辑导致 CDK11 表达显著下降(>75%),进一步调节癌细胞,显著下调参与肿瘤发展和转移的蛋白质(MMP-9 和 VEGF),上调肿瘤抑制蛋白 p53。更重要的是,基因组编辑后的免疫相关蛋白检测表明,Fas、CD80、MICA、MICB 和 HLA-1 的表达显著增强,而 CD47 和 MUC1 的表达降低,表明基因组编辑有利于逆转肿瘤诱导的免疫抑制和预防肿瘤发展。

相似文献

1
Tumor targeted genome editing mediated by a multi-functional gene vector for regulating cell behaviors.多功能基因载体介导的肿瘤靶向基因组编辑调控细胞行为。
J Control Release. 2018 Dec 10;291:90-98. doi: 10.1016/j.jconrel.2018.10.018. Epub 2018 Oct 16.
2
A Dual-Targeting Delivery System for Effective Genome Editing and In Situ Detecting Related Protein Expression in Edited Cells.一种用于有效基因组编辑和原位检测编辑细胞中相关蛋白表达的双靶向递药系统。
Biomacromolecules. 2018 Jul 9;19(7):2957-2968. doi: 10.1021/acs.biomac.8b00511. Epub 2018 Apr 16.
3
Reversal of tumor malignization and modulation of cell behaviors through genome editing mediated by a multi-functional nanovector.通过多功能纳米载体介导的基因组编辑实现肿瘤恶性转化的逆转和细胞行为的调节。
Nanoscale. 2018 Dec 7;10(45):21209-21218. doi: 10.1039/c8nr07321j. Epub 2018 Nov 12.
4
Peptide and Aptamer Decorated Delivery System for Targeting Delivery of Cas9/sgRNA Plasmid To Mediate Antitumor Genome Editing.肽和适体修饰的递药系统,用于靶向递送 Cas9/sgRNA 质粒以介导抗肿瘤基因组编辑。
ACS Appl Mater Interfaces. 2019 Jul 10;11(27):23870-23879. doi: 10.1021/acsami.9b05772. Epub 2019 Jul 1.
5
Multifunctional Vector for Delivery of Genome Editing Plasmid Targeting β-Catenin to Remodulate Cancer Cell Properties.多功能载体递送靶向β-连环蛋白的基因组编辑质粒以重塑癌细胞特性。
ACS Appl Mater Interfaces. 2019 Jan 9;11(1):226-237. doi: 10.1021/acsami.8b17481. Epub 2018 Dec 26.
6
Aptamer/Peptide-Functionalized Genome-Editing System for Effective Immune Restoration through Reversal of PD-L1-Mediated Cancer Immunosuppression.适体/肽修饰的基因组编辑系统通过逆转 PD-L1 介导的癌症免疫抑制实现有效的免疫恢复。
Adv Mater. 2020 Apr;32(17):e2000208. doi: 10.1002/adma.202000208. Epub 2020 Mar 9.
7
Self-Assembled Plasmid Delivery System for PPM1D Knockout to Reverse Tumor Malignancy.用于敲除PPM1D以逆转肿瘤恶性程度的自组装质粒递送系统。
ACS Appl Bio Mater. 2020 Nov 16;3(11):7831-7839. doi: 10.1021/acsabm.0c01009. Epub 2020 Nov 5.
8
Artificial Virus Delivers CRISPR-Cas9 System for Genome Editing of Cells in Mice.人工病毒传递 CRISPR-Cas9 系统用于编辑小鼠细胞基因组。
ACS Nano. 2017 Jan 24;11(1):95-111. doi: 10.1021/acsnano.6b04261. Epub 2016 Nov 17.
9
Restoring the p53 'Guardian' Phenotype in p53-Deficient Tumor Cells with CRISPR/Cas9.利用 CRISPR/Cas9 技术恢复 p53 缺陷型肿瘤细胞中的 p53“守护者”表型。
Trends Biotechnol. 2018 Jul;36(7):653-660. doi: 10.1016/j.tibtech.2018.01.014. Epub 2018 Feb 22.
10
Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide.通过膜破坏和内体溶解的螺旋多肽实现 CRISPR/Cas9 传递的非病毒基因编辑。
Proc Natl Acad Sci U S A. 2018 May 8;115(19):4903-4908. doi: 10.1073/pnas.1712963115. Epub 2018 Apr 23.

引用本文的文献

1
Functionalized chitosan as nano-delivery platform for CRISPR-Cas9 in cancer treatment.功能化壳聚糖作为CRISPR-Cas9在癌症治疗中的纳米递送平台。
Asian J Pharm Sci. 2025 Jun;20(3):101041. doi: 10.1016/j.ajps.2025.101041. Epub 2025 Feb 26.
2
CRISPR/Cas9 Delivery Systems to Enhance Gene Editing Efficiency.用于提高基因编辑效率的CRISPR/Cas9递送系统。
Int J Mol Sci. 2025 May 6;26(9):4420. doi: 10.3390/ijms26094420.
3
Exploring Advanced CRISPR Delivery Technologies for Therapeutic Genome Editing.探索用于治疗性基因组编辑的先进CRISPR递送技术。
Small Sci. 2024 Jul 25;4(10):2400192. doi: 10.1002/smsc.202400192. eCollection 2024 Oct.
4
Biomaterial-Based CRISPR/Cas9 Delivery Systems for Tumor Treatment.用于肿瘤治疗的基于生物材料的CRISPR/Cas9递送系统
Biomater Res. 2024 Apr 30;28:0023. doi: 10.34133/bmr.0023. eCollection 2024.
5
Natural Biopolymer-Based Delivery of CRISPR/Cas9 for Cancer Treatment.基于天然生物聚合物的CRISPR/Cas9递送用于癌症治疗
Pharmaceutics. 2023 Dec 30;16(1):62. doi: 10.3390/pharmaceutics16010062.
6
Intelligent nanotherapeutic strategies for the delivery of CRISPR system.用于递送CRISPR系统的智能纳米治疗策略。
Acta Pharm Sin B. 2023 Jun;13(6):2510-2543. doi: 10.1016/j.apsb.2022.12.013. Epub 2022 Dec 22.
7
Carrier strategies boost the application of CRISPR/Cas system in gene therapy.载体策略推动了CRISPR/Cas系统在基因治疗中的应用。
Exploration (Beijing). 2022 Mar 15;2(2):20210081. doi: 10.1002/EXP.20210081. eCollection 2022 Apr.
8
Recent progress in polymeric gene vectors: Delivery mechanisms, molecular designs, and applications.聚合物基因载体的最新进展:递送机制、分子设计及应用
Biophys Rev (Melville). 2023 Mar;4(1):011313. doi: 10.1063/5.0123664. Epub 2023 Mar 28.
9
Nanomaterial-assisted CRISPR gene-engineering - A hallmark for triple-negative breast cancer therapeutics advancement.纳米材料辅助的CRISPR基因工程——三阴性乳腺癌治疗进展的一个标志。
Mater Today Bio. 2022 Oct 4;16:100450. doi: 10.1016/j.mtbio.2022.100450. eCollection 2022 Dec.
10
Current updates of CRISPR/Cas9-mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management.CRISPR/Cas9 介导的基因组编辑和肿瘤细胞内靶向的最新进展:癌症管理的创新策略。
Cancer Commun (Lond). 2022 Dec;42(12):1257-1287. doi: 10.1002/cac2.12366. Epub 2022 Oct 9.